Skip to content
ESPT
MARKETS / NASDAQ / Health care / Medical devices and instruments / CAMT
NASDAQ · OPTICAL INSTRUMENTS & LENSES · LARGE CAP

Camtek Ltd. CAMT

17 fiscal years on record · USD · FY2025 reported · SEC filings only
$496.1M
▲ 15.6% YoY
$50.7M
▼ 57.2% YoY
$127.5M
▲ 13.7% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Camtek Ltd. is a developer and manufacturer of inspection and metrology equipment for the semiconductor industry. Camtek's systems inspect IC and measure IC features on wafers throughout the production process of semiconductor devices, covering the back-end-of-line (BEOL) of the front-end and mid-end and up to the beginning of assembly (Post Dicing). The company provides customer support for its customers through wholly owned subsidiaries located in 8 offices around the world. Its main office, manufacturing and research and development facilities are located in the Ramat Gavriel Industrial Zone of Migdal Ha’Emek in northern Israel, occupying 164,000 square feet of which 90,800 square feet are devoted to the manufacturing of its products. Camtek Ltd. was incorporated under the laws of the State of Israel in 1987 and operates under the Companies Law. The company has been publicly traded since July 2000.

Written from the business description in Camtek Ltd.'s annual report to the U.S. Securities and Exchange Commission, filed 19 March 2026. Every sentence was checked against that document before publication.

Growth

USD 496.1M
Revenue, FY2025 · full 17-year series below
Revenue $M Net income $M
FY2025 · Revenue 496.1 · Net income 50.7
200M400M
2009201220152018202120242025
Compound annual growth
+15.6%
+26.1%
+21.7%
+12.2%
−14.1%
+18.4%
+21.3%
−14.8%
+14.0%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +26.1% a year over the five years to FY2025 — but profit grew slower: net income at +18.4%, earnings per share at +14.0%.

The share count rose from 0.04B to 0.05B over the period.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

10 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 25.8% · Net 10.2%
10%20%-10%-20%
200920172025
ROE
FY2025 · ROE 8.7%
10%20%-10%-20%
200920172025
Three returns, three denominators.
Gross margin50.5%
Operating margin25.8%
Net margin10.2%
EBITDAUSD 140.0M

Each USD of equity produced 9 cents of profit this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 127.5
50M100M-10M-20M
200920172025
Dividends paid·
Net buybacks·
Share of profit·
Consecutive raises·

Total assetsUSD 1.3B
EquityUSD 617.0M
CashUSD 177.8M
Current ratio8.35×

Equity funds 49% of total assets.

The 17-year record

17 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
CAMT, 17-year financial record
Metric 20252024202320222021202020192018201720162015201420132012201120102009
Revenue $B0.50.40.30.30.30.20.10.10.10.10.10.10.10.10.10.10.1
Operating income $B0.10.10.10.10.10.00.00.0−0.00.0−0.00.00.0−0.00.00.0−0.0
EBITDA $B0.10.10.10.10.10.00.00.0−0.00.0−0.00.00.00.00.00.0−0.0
Income tax $B0.00.00.00.00.00.00.00.0−0.00.0−0.00.0−0.00.00.00.00.0
Net income $B0.10.10.10.10.10.00.00.00.00.0−0.00.00.00.00.00.0−0.0
Free cash flow $B0.10.10.10.00.10.00.00.0−0.0−0.0−0.00.00.00.00.0−0.00.0
EPS, diluted $1.042.421.631.681.340.540.570.510.390.13−0.300.110.000.000.180.09−0.40
Dividend / sh ILS ◌1.33◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend—————————————————
ROE %8.723.118.323.623.112.018.520.217.76.7−15.15.20.00.09.45.4−23.2
Shares out B0.050.050.040.040.040.040.040.040.040.040.040.030.030.030.030.03◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

MCK · COR · CAH · JNJ · HCA · LLY
Provenance

Company facts, as filed

How we verify · 1 failure in 81 reconciliationsAUDITED

Reconciled in 16 of the 17 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Two checks were skipped: EPS is not tagged before 2009. Two checks were skipped: revenue is not tagged before 2009.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency1 failure
ActivityOptical Instruments & Lenses
Listed onNASDAQ
Incorporated inoutside the United States — SEC code L3
Fiscal year endsDecember 31
Data on record since2009

Share this section

Download image